Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chattem Ban Ultra Dry Antiperspirants Kick Off Largest Launch Year Ever

This article was originally published in The Tan Sheet

Executive Summary

Chattem will initiate its most significant launch plan in a single year with two new products under the Ban antiperspirant/deodorant brand - Ultra Dry products in roll-on and stick forms.

You may also be interested in...



Chattem Sunsource Digestive Enzymes Supplement To Debut In February

Chattem is planning to market its Sunsource Omnigest dietary supplement with seven digestive enzymes "more like an OTC" by using certain antacid monograph claims as structure/function claims.

Chattem Sunsource Digestive Enzymes Supplement To Debut In February

Chattem is planning to market its Sunsource Omnigest dietary supplement with seven digestive enzymes "more like an OTC" by using certain antacid monograph claims as structure/function claims.

Chattem Sunsource Digestive Enzymes Supplement To Debut In February

Chattem is planning to market its Sunsource Omnigest dietary supplement with seven digestive enzymes "more like an OTC" by using certain antacid monograph claims as structure/function claims.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS089642

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel